Literature DB >> 24108673

Lack of ADAM10 in endothelial cells affects osteoclasts at the chondro-osseus junction.

Ren Zhao1, Aimin Wang, Katherine C Hall, Miguel Otero, Gisela Weskamp, Baohong Zhao, Daniel Hill, Mary B Goldring, Krzysztof Glomski, Carl P Blobel.   

Abstract

Mice lacking ADAM10 in endothelial cells (Adam10ΔEC mice) have shorter femurs, tibiae, and humeri than controls, raising questions about how endothelial cells could control long bone growth. We performed a histopathological evaluation of the femur and tibia growth plates at different postnatal stages, and assessed the distribution of TRAP-positive osteoclasts and endothelial cells at the growth plate. The growth plates in Adam10ΔEC mice appeared normal at P7 and P14, but a thickened zone of hypertrophic chondrocytes and increased trabecular bone density were apparent by P21 and later. The number of TRAP+ cells at the COJ was normal at P7 and P14, but was strongly reduced at P21 and later. Moreover, the density of endomucin-stained endothelial cells at the COJ was increased starting at P7. The defects in long bone growth in Adam10ΔEC mice could be caused by a lack of osteoclastogenesis at the COJ. Moreover, ADAM10 appears to regulate endothelial cell organization in the developing bone vasculature, perhaps in a similar manner as in the developing retinal vascular tree, where ADAM10 is thought to control Notch-dependent endothelial cell fate decisions. This study provides evidence for the regulation of osteoclast function by endothelial cells in vivo.
© 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  ADAM10; chondro-osseus junction; endothelial cells; growth plate; osteoclasts

Mesh:

Substances:

Year:  2013        PMID: 24108673      PMCID: PMC3978382          DOI: 10.1002/jor.22492

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  17 in total

Review 1.  Reaching a genetic and molecular understanding of skeletal development.

Authors:  Gerard Karsenty; Erwin F Wagner
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

2.  Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.

Authors:  Y Y Kisanuki; R E Hammer; J Miyazaki ; S C Williams; J A Richardson; M Yanagisawa
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

Review 3.  Developmental regulation of the growth plate.

Authors:  Henry M Kronenberg
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

4.  Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

Authors:  Christa Maes; Peter Carmeliet; Karen Moermans; Ingrid Stockmans; Nico Smets; Désiré Collen; Roger Bouillon; Geert Carmeliet
Journal:  Mech Dev       Date:  2002-02       Impact factor: 1.882

5.  KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis.

Authors:  J Rooke; D Pan; T Xu; G M Rubin
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

6.  The metalloprotease-disintegrin Kuzbanian participates in Notch activation during growth and patterning of Drosophila imaginal discs.

Authors:  S Sotillos; F Roch; S Campuzano
Journal:  Development       Date:  1997-12       Impact factor: 6.868

7.  The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.

Authors:  Dieter Hartmann; Bart de Strooper; Lutgarde Serneels; Katleen Craessaerts; An Herreman; Wim Annaert; Lieve Umans; Torben Lübke; Anna Lena Illert; Kurt von Figura; Paul Saftig
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

8.  ADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes.

Authors:  Katherine C Hall; Daniel Hill; Miguel Otero; Darren A Plumb; Dara Froemel; Cecilia L Dragomir; Thorsten Maretzky; Adele Boskey; Howard C Crawford; Licia Selleri; Mary B Goldring; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

9.  Microvascular pattern in the metaphysis during bone growth.

Authors:  S Aharinejad; S C Marks; P Böck; C A MacKay; E K Larson; A Tahamtani; A Mason-Savas; W Firbas
Journal:  Anat Rec       Date:  1995-05

10.  SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling.

Authors:  C Wen; M M Metzstein; I Greenwald
Journal:  Development       Date:  1997-12       Impact factor: 6.868

View more
  4 in total

1.  Second-generation Notch1 activity-trap mouse line (N1IP::CreHI) provides a more comprehensive map of cells experiencing Notch1 activity.

Authors:  Zhenyi Liu; Eric Brunskill; Scott Boyle; Shuang Chen; Mustafa Turkoz; Yuxuan Guo; Rachel Grant; Raphael Kopan
Journal:  Development       Date:  2015-02-27       Impact factor: 6.868

Review 2.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

3.  ADAM10 modulates SOX9 expression via N1ICD during chondrogenesis at the cranial base.

Authors:  Runqing Fu; Xiaoting Wang; Lunguo Xia; Yu Tan; Jiaqiang Liu; Lingjun Yuan; Zhi Yang; Bing Fang
Journal:  RSC Adv       Date:  2018-11-14       Impact factor: 4.036

Review 4.  Targeting ADAM10 in Cancer and Autoimmunity.

Authors:  Timothy M Smith; Anuj Tharakan; Rebecca K Martin
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.